Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical 30% Metformin vs Kligman's Regimen for Melasma
NCT07485777Not yet recruiting
- Sponsor
- Foundation University Islamabad
- Start
- Jul 2026
- Primary completion
- Dec 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, single-blind trial of metformin 1% gel in melasma (2 arms), sponsored by Foundation University Islamabad. Primary endpoint: Modified Melasma Area and Severity Index at 8 weeks. Planned start Jul 2026; status: not yet recruiting.
02
Drugs
metformin 1% gel
03
Conditions
melasma
Beyond the preview
Go deeper on NCT07485777.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07485777.